150 related articles for article (PubMed ID: 16705455)
1. Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma.
Rostagno C; Ciolli S
Ann Hematol; 2006 Sep; 85(9):627-8. PubMed ID: 16705455
[No Abstract] [Full Text] [Related]
2. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
[No Abstract] [Full Text] [Related]
3. Myelomatous pleural effusion.
Ghosh S; Gopal R; Advani SH
J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
[TBL] [Abstract][Full Text] [Related]
4. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
[No Abstract] [Full Text] [Related]
5. Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.
Richardson P; Anderson K
J Clin Oncol; 2006 Jan; 24(3):334-6. PubMed ID: 16365174
[No Abstract] [Full Text] [Related]
6. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
[No Abstract] [Full Text] [Related]
7. Multiple myeloma presenting as plasmacytoma of the base of the skull.
Alegre A; Tomás JF; Pinilla I; Gil-Fernández JJ; Fernández-Rañada JM
Am J Hematol; 1996 May; 52(1):60-1. PubMed ID: 8638614
[No Abstract] [Full Text] [Related]
8. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma.
van der Spek E; Bloem AC; Sinnige HA; Lokhorst HM
Haematologica; 2007 Dec; 92(12):e130-1. PubMed ID: 18055977
[TBL] [Abstract][Full Text] [Related]
9. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
Lila AM; Mazurov VI; Novik AA
Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
[No Abstract] [Full Text] [Related]
10. An unusual case of pulmonary hypertension in a young male.
Rostagno C; Ciolli S; Prisco D
Intern Emerg Med; 2006; 1(2):127-32. PubMed ID: 17111785
[No Abstract] [Full Text] [Related]
11. Successful treatment of multiple myeloma--associated amyloidosis by interferon-alpha, dimethyl sulfoxide, and VAD (vincristine, adriamycin, and dexamethasone).
Ichida M; Imagawa S; Ohmine K; Komatsu N; Hatake K; Ozawa K; Miura Y
Int J Hematol; 2000 Dec; 72(4):491-3. PubMed ID: 11197218
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
13. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with VAD of a myelodysplastic syndrome occurring during the course of a smoldering multiple myeloma.
Cortesão E; Espadana A; Laranjeiro P; Jara M; Orfão A
Leuk Res; 2009 Jan; 33(1):195-7. PubMed ID: 18511113
[No Abstract] [Full Text] [Related]
15. Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?
Jimenez-Zepeda VH; Domínguez-Martínez VJ
Eur J Haematol; 2006 Sep; 77(3):239-44. PubMed ID: 16856924
[TBL] [Abstract][Full Text] [Related]
16. Bulbar palsy in multiple myeloma.
Chim CS; Ooi GC
Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
[No Abstract] [Full Text] [Related]
17. Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
Vogl DT; Liu SV; Chong EA; Luger SM; Porter DL; Schuster SJ; Tsai DE; Perl A; Loren AW; Goldstein SC; Nasta SD; Andreadis C; Mangan PA; Hummel K; Siegel DL; Glatstein E; Stadtmauer EA
Am J Hematol; 2007 Dec; 82(12):1071-5. PubMed ID: 17696204
[TBL] [Abstract][Full Text] [Related]
18. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
19. Controversies regarding the use of dexamethasone in patients with multiple myeloma.
Rajkumar SV
Clin Adv Hematol Oncol; 2008 Feb; 6(2):103, 141. PubMed ID: 18347560
[No Abstract] [Full Text] [Related]
20. Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma.
Dasanu CA; Vaillant JG; Alexandrescu DT
Dermatol Online J; 2006 Oct; 12(6):10. PubMed ID: 17083890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
